"Therapy response" trang 1 - tải miễn phí từ tailieunhanh
Concurrent clinical and pathological response predicts favorable prognosis of patients with gastric cancer after neoadjuvant therapy: A real-world study

Concurrent clinical and pathological response predicts favorable prognosis of patients with gastric cancer after neoadjuvant therapy: A real-world study
10    8    1
Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda

Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda
9    77    0
PDXGEM: Patient-derived tumor xenograftbased gene expression model for predicting clinical response to anticancer therapy in cancer patients

PDXGEM: Patient-derived tumor xenograftbased gene expression model for predicting clinical response to anticancer therapy in cancer patients
21    59    1
Intraoperative radiation therapy induces immune response activity after pancreatic surgery

Intraoperative radiation therapy induces immune response activity after pancreatic surgery
12    54    1
Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data

Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data
11    41    1
Total neoadjuvant therapy with short-course radiotherapy Versus long-course neoadjuvant chemoradiotherapy in Locally Advanced Rectal cancer, Korean trial (TV-LARK trial): Study protocol of a multicentre randomized controlled trial

Total neoadjuvant therapy with short-course radiotherapy Versus long-course neoadjuvant chemoradiotherapy in Locally Advanced Rectal cancer, Korean trial (TV-LARK trial): Study protocol of a multicentre randomized controlled trial
7    1    1
Response biomarkers: Re-envisioning the approach to tailoring drug therapy for cancer

Response biomarkers: Re-envisioning the approach to tailoring drug therapy for cancer
11    55    1
The efficiency of 18F-FDG-PET/CT in the assessment of tumor response to preoperative chemoradiation therapy for locally recurrent rectal cancer

The efficiency of 18F-FDG-PET/CT in the assessment of tumor response to preoperative chemoradiation therapy for locally recurrent rectal cancer
10    36    1
Ebook Animal assisted therapy in counseling: Part 2

Ebook Animal assisted therapy in counseling: Part 2
113    1    1
An agent-based model of prostate Cancer bone metastasis progression and response to Radium223

An agent-based model of prostate Cancer bone metastasis progression and response to Radium223
19    50    1
MRI in predicting the response of gastrointestinal stromal tumor to targeted therapy: A patient-based multi-parameter study

MRI in predicting the response of gastrointestinal stromal tumor to targeted therapy: A patient-based multi-parameter study
8    55    1
Radiographic response to neoadjuvant therapy and its impact on scope of surgery and prognosis in stage IIB/III soft tissue sarcomas

Radiographic response to neoadjuvant therapy and its impact on scope of surgery and prognosis in stage IIB/III soft tissue sarcomas
9    52    1
Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation

Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation
5    58    1
Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: A multicenter study

Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: A multicenter study
12    6    1
Pancytopenia and lymphoid organ hyperplasia in a patient with graves disease: Response to antithyroid drug therapy

Pancytopenia and lymphoid organ hyperplasia in a patient with graves disease: Response to antithyroid drug therapy
5    71    0
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma

VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma
7    40    1
Valuation of the CT LI-RADS treatment response V2018 in patients after first-line deb tace) for hepatocellular carcinoma (HCC)

Valuation of the CT LI-RADS treatment response V2018 in patients after first-line deb tace) for hepatocellular carcinoma (HCC)
8    1    1
Immune- and miRNA-response to recombinant interferon beta-1a: A biomarker evaluation study to guide the development of novel type I interferon- based therapies

Immune- and miRNA-response to recombinant interferon beta-1a: A biomarker evaluation study to guide the development of novel type I interferon- based therapies
6    87    0
Achieving objective response in treatment of non-resectable neuroendocrine tumors does not predict longer time to progression compared to achieving stable disease

Achieving objective response in treatment of non-resectable neuroendocrine tumors does not predict longer time to progression compared to achieving stable disease
7    74    0
Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response

Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response
12    97    0